전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,403 programs
AntibodyLimited DatastaleBeiGenePhase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48 Combined With Tislelizumab)

Upper Tract Urothelial Carcinoma · PD-1

#PD-1#Antibody#Phase2#monoclonal-antibody#UpperTractUrothelialCarcinoma+1
Trials 12Status Recruiting
CGTCurated CorestaleREGENXBIO Inc.Phase 2

RGX-314 (RGX-314)

Neovascular Age-related Macular Degeneration; Wet Age-related Macular Degeneration · Neovascular Age-related Macular Degenera

#NeovascularAge-relatedMacularDeg#CGT#Phase2#BioJungboMoa-pick#cell-gene-therapy+4
Trials 12Status Active
CGTLimited DatastaleFundamenta Therapeutics, Ltd.Phase 1

ThisCART19A (ThisCART19A)

Non-Hodgkin's Lymphoma · Allogeneic, CAR-T, Protein Sequestration

#AllogeneicCAR-TProteinSequestrat#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 12Status Recruiting
CGTLimited DatastaleHrain Biotechnology Co., Ltd.Phase 1

anti-MESO CAR-T cells (anti-MESO CAR-T cells)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 12Status Active
CGTLimited DatastaleXi'niao BiotechPhase 1

universal allogeneic anti-CD19/BCMA CAR T-cells (universal allogeneic anti-CD19/BCMA CAR T-cells)

Autoimmune Hemolytic Anemia; CD19/BCMA CAR T-cells · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 12Status Recruiting
CGTLimited DatastaleTaiho Oncology, Inc.Phase 2

ASTX660 (ASTX660)

Solid Tumors; Lymphoma · Solid Tumors

#SolidTumors#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 11Status Recruiting
ADCLimited DatastaleLepu Biopharma Co., Ltd.Phase 2

Becotatug Vedotin and Pucotenlimab (Becotatug Vedotin and Pucotenlimab)

Hypopharyngeal Squamous Cell Carcinoma · Nasopharyngeal Cancinoma (NPC)

#NasopharyngealCancinomaNPC#ADC#Phase2#antibody-drug-conjugate#HypopharyngealSquamousCellCarcin+1
Trials 11Status Recruiting
AntibodyLimited DatastaleShi MingPhase 2

Candonilimab (Candonilimab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#Shi
Trials 11Status Discontinued
ADCStandard DatabasestaleAstraZenecaPhase 2

durvalumab (Imfinzi, Datopotamab deruxtecan + Durvalumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#antibody-drug-conjugate#BreastNeoplasms+2
Trials 11Status Recruiting
CGTLimited DatastaleBeijing Immunochina Medical Sci…Phase 2

IM19 CAR-T (IM19 CAR-T)

Leukemia · Leukemia

#Leukemia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 11Status Active
CGTLimited DatastaleKyverna TherapeuticsPhase 2

KYV-101 anti-CD19 CAR-T cell therapy (KYV-101 anti-CD19 CAR-T cell therapy)

Lupus Nephritis; Lupus Nephritis - WHO Class III · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 11Status Discontinued
AntibodyLimited DatastaleLepu Medical Technology (Beijin…Phase 2

MRG003+Pucotenlimab (MRG003+Pucotenlimab)

Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma · Locally Advanced Oral and Oropharyngeal

#LocallyAdvancedOralandOropharyng#Antibody#Phase2#monoclonal-antibody#Lepu
Trials 11Status Recruiting
AntibodyLimited DatastaleAmgenPhase 2

Panitumumab-IRDye800 (Panitumumab-IRDye800)

Pancreatic Adenocarcinoma · Malignant Brain Neoplasm

#MalignantBrainNeoplasm#Antibody#Phase2#monoclonal-antibody#PancreaticAdenocarcinoma+1
Trials 11Status Recruiting
AntibodyLimited DatastaleJanssenPhase 1

Topical infliximab (Topical infliximab)

Sterile Corneal Melt · Glaucoma Following Surgery

#GlaucomaFollowingSurgery#Antibody#Phase1#monoclonal-antibody#SterileCornealMelt+1
Trials 11Status Active
CGTLimited DatastaleCARsgen Therapeutics Co., Ltd.Phase 1

anti-GPC3 CAR-T (anti-GPC3 CAR-T)

Advanced Hepatocellular Carcinoma · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 11Status Recruiting
CGTLimited DatastaleNational Heart, Lung, and Blood…Phase 1

AVL (AAV8hAAT, AAV8hAAT(AVL))

Alpha 1-Antitrypsin Deficiency · Alpha 1-Antitrypsin Deficiency

#Alpha1-AntitrypsinDeficiency#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 10Status Recruiting
CGTLimited DatastaleAsclepius Technology Company Gr…Phase 1

Anti-BCMA CAR-NK Cells (Anti-BCMA CAR-NK Cells)

Multiple Myeloma, Refractory · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 10Status Active
CGTStandard DatabasestaleTakedaPhase 2

Anti-CD19 CAR T Cells Preparation (Anti-CD19 CAR T Cells Preparation)

Hematologic Malignancies · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 10Status Recruiting
AntibodyLimited DatastaleGenentech, Inc.Phase 3

Cevostamab (Cevostamab)

Relapsed or Refractory Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#monoclonal-antibody#RelapsedorRefractoryMultipleMyel+1
Trials 10Status Recruiting
CGTLimited DatastaleShenzhen Celconta Life Science …Phase 1

Claudin18.2-targeted CAR-T Cells (Claudin18.2-targeted CAR-T Cells)

Colorectal Neoplasia · Colorectal Neoplasia

#ColorectalNeoplasia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 10Status Recruiting

24 / 121 pages

← PreviousNext →